FDA Inspection
Cdymax (India) Pharma Private LimitedCdymax (India) Pharma Private Limited – FDA Inspection, May 17, 2019
Record Details
This FDA Inspection record concerns Cdymax (India) Pharma Private Limited, with an inspection on May 17, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · af0d07d5-0d83-4b81-886c-3d7911eee80b
Inspection Facts
- Inspection number
- 1093684
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Cdymax (India) Pharma Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cdymax (India) Pharma Private Limited
- FDA Inspection 1271325 - 2025-04-25
- FDA Inspection 1118683 - 2020-01-31
- FDA Inspection 940635 - 2015-08-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.